The Novel Effects of a Hydrolyzed Polysaccharide Dietary Supplement on Immune, Hepatic, and Renal Function in Adults with HIV in a Randomized, Double-Blind, Placebo-Control Trial

References

• Adleman LM, Wofsy D. 1993. T-cell homeostasis: Implications in HIV infection. J Acquir Immune Defic Syndr. 6(2):144–152.
   PubMed Web of Science ®Google Scholar
• Ali K, Melillo A, Leonard S, Asthana D, Woolger J, Wolfson A, McDaniel H, Lewis J. 2012. An open-label, randomized clinical trial to assess the immunomodulatory activity of a novel oligosaccharide compound in healthy adults. FFHD. 2(7):265–279. doi:10.31989/ffhd.v2i7.84.
   Google Scholar
• Appay V, Sauce D. 2008. Immune activation and inflammation in HIV-1 infection: Causes and consequences. J Pathol. 214(2):231–241. doi:10.1002/path.2276.
   PubMed Web of Science ®Google Scholar
• Buggert M, Frederiksen J, Noyan K, Svard J, Barqasho B, Sonnerborg A, Lund O, Nowak P, Karlsson AC. 2014. Multiparametric bioinformatics distinguish the CD4/CD8 ratio as a suitable laboratory predictor of combined T cell pathogenesis in HIV infection. J Immunol. 192(5):2099–2108. doi:10.4049/jimmunol.1302596.
   PubMed Web of Science ®Google Scholar
• Caby F, Guihot A, Lambert-Niclot S, Guiguet M, Boutolleau D, Agher R, Valantin MA, Tubiana R, Calvez V, Marcelin AG, et al. 2016. Determinants of a low CD4/CD8 ratio in HIV-1-infected individuals despite long-term viral suppression. Clin Infect Dis. 62(10):1297–1303. doi:10.1093/cid/ciw076.
   PubMed Web of Science ®Google Scholar
• Caby F, Writing committee of the CD4+/CD8+ Ratio Working Group of the French Hospital Database on HIV (FHDH-ANRS CO4). 2017. CD4+/CD8+ ratio restoration in long-term treated HIV-1-infected individuals. AIDS. 31(12):1685–1695.
   Google Scholar
• Centers for Disease Control and Prevention. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Weekly Rep. 41(51):961–962.
   Google Scholar
• Centers for Disease Control and Prevention. 2008. HIV prevalence estimates–United States, 2006. MMWR Morb Mortal Wkly Rep. 57(39):1073–1076.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. 2016. HIV surveillance report, 2015. [accessed May 12, 2017]. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.
   Google Scholar
• Cholujova D, Jakubikova J, Czako B, Martisova M, Hunakova L, Duraj J, Mistrik M, Sedlak J. 2013. MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients. Cancer Immunol Immunother. 62(3):437–445. doi:10.1007/s00262-012-1344-z.
   PubMed Web of Science ®Google Scholar
• De Biasi S, Bianchini E, Nasi M, Digaetano M, Gibellini L, Carnevale G, Borghi V, Guaraldi G, Pinti M, Mussini C, et al. 2016. Th1 and th17 proinflammatory profile characterizes invariant natural killer T cells in virologically suppressed HIV + patients with low CD4+/CD8+ ratio. AIDS. 30(17):2599–2610. doi:10.1097/QAD.0000000000001247.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Agrawal S. 2014. MGN3/biobran enhances generation of cytotoxic CD8+ T cells via upregulation of dec-205 expression on dendritic cells. Int J Immunopathol Pharmacol. 27(4):523–530. doi:10.1177/039463201402700408.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Matsuura M. 2004. Augmentation of macrophage phagocytosis by modified arabinoxylan rice bran (MGN-3/biobran). Int J Immunopathol Pharmacol. 17(3):283–292. doi:10.1177/039463200401700308.
   PubMed Web of Science ®Google Scholar
• Ghoneum M. 1998a. Anti-HIV activity in vitro of MGN-3, an activated arabinoxylane from rice bran. Biochem Biophys Res Commun. 243(1):25–29. doi:10.1006/bbrc.1997.8047.
   PubMed Web of Science ®Google Scholar
• Ghoneum M. 1998b. Enhancement of human natural killer cell activity by modified arabinoxylan from rice bran MGN-3. Int J Immunotherapy. 14(2):89–99.
   Web of Science ®Google Scholar
• Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, Hamann D, Prins M, Miedema F. 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 17(13):1881–1888. doi:10.1097/01.aids.0000076311.76477.6e.
   PubMed Web of Science ®Google Scholar
• Hema MN, Ferry T, Dupon M, Cuzin L, Verdon R, Thiebaut R, Protopopescu C, Leport C, Raffi F, Le Moing V. 2016. Low CD4/CD8 ratio is associated with non aids-defining cancers in patients on antiretroviral therapy: Anrs co8 (aproco/copilote) prospective cohort study. PLoS One. 11(8):e0161594. doi:10.1371/journal.pone.0161594.
   PubMed Web of Science ®Google Scholar
• Ivanov AV, Valuev-Elliston VT, Ivanova ON, Kochetkov SN, Starodubova ES, Bartosch B, Isaguliants MG. 2016. Oxidative stress during HIV infection: Mechanisms and consequences. Oxid Med Cell Longev. 2016:8910396. doi:10.1155/2016/8910396.
   PubMed Web of Science ®Google Scholar
• Kalebic T, Kinter A, Poli G, Anderson ME, Meister A, Fauci AS. 1991. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and n-acetylcysteine. Proc Natl Acad Sci Usa. 88(3):986–990. doi:10.1073/pnas.88.3.986.
   PubMed Web of Science ®Google Scholar
• Krantz EM, Hullsiek KH, Okulicz JF, Weintrob AC, Agan BK, Crum-Cianflone NF, Ganesan A, Ferguson TM, Hale BR, Infectious Disease Clinical Research Program H. 2011. Elevated CD8 counts during haart are associated with HIV virologic treatment failure. J Acquir Immune Defic Syndr. 57(5):396–403. doi:10.1097/QAI.0b013e318221c62a.
   PubMed Web of Science ®Google Scholar
• Ku NS, Jiamsakul A, Ng OT, Yunihastuti E, Cuong DD, Lee MP, Sim BL, Phanuphak P, Wong WW, Kamarulzaman A, et al. 2016. Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy. Medicine. 95(32):e4570. doi:10.1097/MD.0000000000004570.
   PubMed Web of Science ®Google Scholar
• Lewis JE, Atlas SE, Higuera OL, Fiallo A, Rasul A, Farooqi A, Kromo O, Lantigua LA, Tiozzo E, Woolger JM, et al. 2018. The effect of a hydrolyzed polysaccharide dietary supplement on biomarkers in adults with nonalcoholic fatty liver disease. Evid Based Complement Alternat Med. 2018:1751583. doi:10.1155/2018/1751583.
   PubMed Web of Science ®Google Scholar
• Merci NM, Emerence U, Augustin N, Habtu M, Julie I, Angelique T, Jessica B, Cynthia A, Penda AT. 2017. CD4+ cells recovery in HIV positive patients with severe immunosuppression at HAART initiation at centre medico-social corunum, kigali. Pan Afr Med J. 26:14. doi:10.11604/pamj.2017.26.14.10488.
   PubMedGoogle Scholar
• Mussini C, Lorenzini P, Cozzi-Lepri A, Lapadula G, Marchetti G, Nicastri E, Cingolani A, Lichtner M, Antinori A, Gori A, et al. 2015. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. Lancet HIV. 2(3):e98–106. doi:10.1016/S2352-3018(15)00006-5.
   PubMed Web of Science ®Google Scholar
• Nanzigu S, Kiguba R, Kabanda J, Mukonzo JK, Waako P, Kityo C, Makumbi F. 2013. Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans. HIV AIDS (Auckl). 5:309–319. doi:10.2147/HIV.S50614.
   PubMedGoogle Scholar
• Serrano-Villar S, Moreno S, Fuentes-Ferrer M, Sanchez-Marcos C, Avila M, Sainz T, de Villar NG, Fernandez-Cruz A, Estrada V. 2014. The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery. HIV Med. 15(1):40–49. doi:10.1111/hiv.12081.
   PubMed Web of Science ®Google Scholar
• Tazawa K, Namikawa H, Oida N, Masada M, Maeda H. 2000. Scavenging activity of modified arabinoxylane from rice bran (BioBran/MGN-3) with natural killer cell activity on free radicals. Biotherapy. 14:493–495.
   Google Scholar
• Tinago W, Coghlan E, Macken A, McAndrews J, Doak B, Prior-Fuller C, Lambert JS, Sheehan GJ, Mallon PW; Mater Immunology Study G. 2014. Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: Effect of naive and memory t-cell subsets. PLoS One. 9(5):e97011. doi:10.1371/journal.pone.0097011.
   PubMed Web of Science ®Google Scholar
• Zheng L, Taiwo B, Gandhi RT, Hunt PW, Collier AC, Flexner C, Bosch RJ. 2014. Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy. J Acquir Immune Defic Syndr. 67(2):153–160. doi:10.1097/QAI.0000000000000286.
   PubMed Web of Science ®Google Scholar